World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
15261
World Ranking
2847
National Ranking
188

Sven Brandau publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sven Brandau sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 196 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sven Brandau D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sven Brandau sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sven Brandau is affiliated with the University of Duisburg-Essen in Germany and has an extensive research portfolio primarily within the fields of immunology, microbiology, medicine, biochemistry, genetics, and molecular biology. Their scholarly contributions span multiple subfields, including immunology, molecular biology, oncology, genetics, and cancer research, reflecting a broad and interdisciplinary research focus.

Their research topics broadly encompass areas such as:

  • Immune cells in cancer
  • Neutrophil, myeloperoxidase and oxidative mechanisms
  • Immune cell function and interaction
  • Immune response and inflammation
  • Extracellular vesicles in disease
  • Mesenchymal stem cell research
  • Inflammatory biomarkers in disease prognosis

Several recent papers illustrate the scope and depth of their work, including:

  • Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation (2020, Journal for ImmunoTherapy of Cancer)
  • N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology (2022, Immunological Reviews)
  • Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro (2020, Blood Advances)
  • Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model (2023, Cytotherapy)
  • Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands (2023, Frontiers in Immunology)

Frequent publication venues for Sven Brandau include:

  • Laryngo-Rhino-Otologie
  • Cytotherapy
  • Frontiers in Immunology
  • HNO
  • Journal for ImmunoTherapy of Cancer

Their collaboration network features several frequent coauthors, notably:

  • Kirsten Bruderek
  • Stephan Lang
  • Peter A. Horn
  • Timon Hussain
  • Simon F. Merz

In addition to journal articles, Sven Brandau has contributed to book literature, including a publication titled Myeloid-Derived Suppressor Cells released by Springer Science+Business Media in 2020.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

    Claudia A. Dumitru;Katrin Moses;Sokratis Trellakis;Stephan Lang

  • Type I IFNs induce anti‐tumor polarization of tumor associated neutrophils in mice and human

    Lisa Andzinski;Nadine Kasnitz;Stephanie Stahnke;Ching-Fang Wu

  • Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties

    Sven Brandau;Sokratis Trellakis;Kirsten Bruderek;Dominik Schmaltz

  • Immune Mechanisms in Bacillus Calmette-Guerin Immunotherapy for Superficial Bladder Cancer

    Andreas Böhle;Sven Brandau

  • Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.

    Claudia A. Dumitru;Stephan Lang;Sven Brandau

  • Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.

    Katrin Moses;Sven Brandau

  • Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.

    Sokratis Trellakis;Kirsten Bruderek;Claudia A. Dumitru;Hossein Gholaman

  • Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes.

    Anja Hasenberg;Mike Hasenberg;Linda Männ;Franziska Neumann

  • Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses

    Henrik Suttmann;Josef Riemensberger;Gabriele Bentien;Dominik Schmaltz

  • NK cells are essential for effective BCG immunotherapy

    Sven Brandau;Josef Riemensberger;Marc Jacobsen;Don Kemp

  • Thirty Years of BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer: A Success Story With Room for Improvement

    Sven Brandau;Henrik Suttmann

  • PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

    Benjamin A. Kansy;Benjamin A. Kansy;Fernando Concha-Benavente;Raghvendra M. Srivastava;Hyun Bae Jie

  • Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.

    Stephan Lang;Kirsten Bruderek;Cordelia Kaspar;Benedikt Höing

  • Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

    Susanna Mandruzzato;Sven Brandau;Cedrik M. Britten;Cedrik M. Britten;Vincenzo Bronte

  • Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice

    Aly S;Wagner K;Keller C;Malm S

  • Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

    Luca Cassetta;Espen Sønderaal Bækkevold;Sven Brandau;Anna Bujko

  • Genetically Determined Susceptibility to Tuberculosis in Mice Causally Involves Accelerated and Enhanced Recruitment of Granulocytes

    Christine Keller;Reinhard Hoffmann;Roland Lang;Sven Brandau

  • Interferon-γ and Tumor Necrosis Factor-α Differentially Affect Cytokine Expression and Migration Properties of Mesenchymal Stem Cells

    Hatim Hemeda;Mark Jakob;Anna-Kristin Ludwig;Bernd Giebel

  • The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?

    Sven Brandau;Katrin Moses;Stephan Lang

  • Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge.

    Sven Brandau;Mark Jakob;Mark Jakob;Hatim Hemeda;Kirsten Bruderek

Frequent Co-Authors

Christopher Barner-Kowollik
Christopher Barner-Kowollik Queensland University of Technology
Matthias Gunzer
Matthias Gunzer University of Duisburg-Essen
Matthias Epple
Matthias Epple University of Duisburg-Essen
Torsten Goldmann
Torsten Goldmann Research Center Borstel - Leibniz-Center for Medicine and Biosciences
Bernd Giebel
Bernd Giebel University of Duisburg-Essen
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
Jan Buer
Jan Buer University of Duisburg-Essen
Viktor Umansky
Viktor Umansky Heidelberg University
Yu Lei
Yu Lei Sun Yat-sen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into nursing and healthcare careers is a valuable option. Many professionals choose to advance their expertise through specialized nursing programs. For example, if you’re currently a Family Nurse Practitioner, exploring an fnp to acnp bridge program online can help you transition into acute care nursing roles that intersect with immunological patient care.

Accelerated learning paths are also popular, allowing students with relevant backgrounds to fast-track their careers. The best programs are designed to equip nurses with essential skills quickly, as highlighted in the overview of accelerated nurse practitioner programs.

For individuals without prior nursing experience but a keen interest in healthcare and immunology, the best online rn programs for non nurses offer accessible pathways to enter the nursing profession and open up immunology-related specialties.

Considering career outcomes, it’s important to review salary expectations. Understanding how much does a dnp make across different states helps in making informed decisions about education investments and job locations within healthcare and immunology fields.

Best Scientists Citing Sven Brandau

Trending Scientists

Recently Published Articles